75,000 Shares in Amedisys, Inc. (NASDAQ:AMED) Bought by Oddo BHF Asset Management Sas

Oddo BHF Asset Management Sas purchased a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 75,000 shares of the health services provider's stock, valued at approximately $7,238,000. Oddo BHF Asset Management Sas owned approximately 0.23% of Amedisys at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Polar Asset Management Partners Inc. acquired a new stake in Amedisys during the 3rd quarter worth approximately $28,953,000. SG Americas Securities LLC raised its position in shares of Amedisys by 413.4% during the 3rd quarter. SG Americas Securities LLC now owns 196,713 shares of the health services provider's stock worth $18,985,000 after buying an additional 158,398 shares in the last quarter. Verition Fund Management LLC lifted its holdings in Amedisys by 608.1% in the 3rd quarter. Verition Fund Management LLC now owns 114,774 shares of the health services provider's stock valued at $11,077,000 after acquiring an additional 98,565 shares during the last quarter. Westchester Capital Management LLC grew its holdings in shares of Amedisys by 9.5% in the 3rd quarter. Westchester Capital Management LLC now owns 1,118,802 shares of the health services provider's stock worth $107,976,000 after acquiring an additional 97,476 shares during the last quarter. Finally, Highbridge Capital Management LLC boosted its stake in Amedisys by 34.7% in the 2nd quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider's stock worth $29,670,000 after purchasing an additional 83,200 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Stock Up 0.1 %

NASDAQ AMED traded up $0.08 on Friday, reaching $85.68. The stock had a trading volume of 365,885 shares, compared to its average volume of 372,868. Amedisys, Inc. has a 1 year low of $84.06 and a 1 year high of $98.95. The business has a 50 day moving average price of $92.87 and a 200 day moving average price of $95.02. The company has a market capitalization of $2.81 billion, a price-to-earnings ratio of 33.97, a P/E/G ratio of 1.84 and a beta of 0.73. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its earnings results on Wednesday, November 6th. The health services provider reported $1.00 EPS for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The firm had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. During the same quarter in the previous year, the company posted $0.98 earnings per share. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. On average, analysts forecast that Amedisys, Inc. will post 4.45 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.